Shoulder Innovations, Inc. announced the promotion of Jon Osborne to Chief Commercial Officer, effective August 6, 2026. Osborne previously served as Vice President of Commercial Development and will oversee all commercial operations, working with Customer Experience and Medical Education teams to execute strategy. He brings extensive orthopedic industry experience from prior roles at Smith & Nephew Inc., ArthroCare Corporation, Tornier USA, and Team Surgical, Inc. Shoulder Innovations is a medical technology company focused on transforming the shoulder surgical care market through advanced implant systems for shoulder arthroplasty.

Shoulder Innovations reported second quarter 2026 net revenue of $17.2 million, a 56% increase from the prior year period, driven by a 50% rise in implant system sales to 2,238 units and higher average selling prices. The company raised its full-year 2026 net revenue guidance to $67–$69 million, reflecting approximately 42–46% growth over 2025. Additionally, Shoulder Innovations closed two new credit facilities totaling up to $50 million with Stifel Venture Banking to refinance existing debt and secure working capital capacity. The company operates in the medical technology industry, specializing in implant systems for shoulder arthroplasty.

On June 26, 2026, Shoulder Innovations, Inc. entered into a Loan and Security Agreement with Stifel Bank, providing a $15.0 million senior secured term loan and a $30.0 million senior secured asset-based revolving line of credit, which may increase by $5.0 million. The company used the term loan proceeds to voluntarily prepay and terminate its $15.7 million outstanding debt with Trinity Capital Inc. The term loan matures on June 1, 2031, while the revolving facility matures on June 26, 2029. The new credit facilities are secured by substantially all company assets, excluding intellectual property. Shoulder Innovations, Inc. is a medical technology company specializing in surgical solutions.